{
  "MasterItem": {
    "id": "NCLEX_Highlight_CardioShock_001",
    "itemType": "highlight",
    "stem": "The nurse is reviewing the client's electronic health record (EHR) and preparing to administer the 0900 (9:00 AM) medications. Click to highlight the finding in the Nurses' Note that requires the nurse to withhold the scheduled medications and contact the provider for immediate intervention.",
    "tabs": [
      {
        "id": "nursesNote",
        "label": "Nurses' Note",
        "content": "0730 (7:30 AM): Client is a 68-year-old male admitted to the CVICU post-emergent PCI for an extensive anterior wall STEMI. Client states he had intermittent chest pain for 3 days but delayed seeking care due to being the sole caregiver for his spouse. He is currently lethargic but oriented to person and place. Skin is cool and diaphoretic. Bilateral basilar crackles are noted on auscultation. Urine output has decreased to 15 mL/hr for the past 2 hours, and the urine is dark amber. Morning laboratory results have been reviewed and show a potassium of 6.8 mEq/L and a creatinine of 2.5 mg/dL. The client remains on continuous norepinephrine and dobutamine infusions for hemodynamic support."
      },
      {
        "id": "vitals",
        "label": "Vital Signs",
        "content": "Trended Vital Signs:\n| Time  | BP (mmHg) | HR (bpm) | RR (breaths/min) | SpO2 (%) | Temp (Â°F) |\n|-------|-----------|----------|------------------|----------|-----------|\n| 0500 (5:00 AM) | 94/62     | 105      | 22               | 93%      | 98.8      |\n| 0600 (6:00 AM) | 90/60     | 110      | 24               | 92%      | 98.7      |\n| 0700 (7:00 AM) | 88/60     | 118      | 26               | 91%      | 98.8      |\n| 0800 (8:00 AM) | 86/58     | 122      | 26               | 91%      | 98.6      |"
      },
      {
        "id": "labs",
        "label": "Laboratory Results",
        "content": "Today at 0600 (6:00 AM):\n- Potassium: 6.8 mEq/L (HIGH)\n- Sodium: 137 mEq/L\n- BUN: 55 mg/dL (HIGH)\n- Creatinine: 2.5 mg/dL (HIGH)\n- Troponin I: 45.2 ng/mL (HIGH)\n- Lactate: 4.8 mmol/L (HIGH)\n\nYesterday at 1800 (6:00 PM):\n- Potassium: 4.2 mEq/L\n- Creatinine: 1.1 mg/dL"
      },
      {
        "id": "mar",
        "label": "Medication Administration Record",
        "content": "Scheduled Medications for 0900 (9:00 AM) Administration:\n- Aspirin 81 mg PO daily\n- Clopidogrel 75 mg PO daily\n- Atorvastatin 80 mg PO daily\n- Spironolactone 25 mg PO daily\n- Furosemide 40 mg IV push daily"
      }
    ],
    "options": [
      {
        "id": "opt_01",
        "content": "Client states he had intermittent chest pain for 3 days but delayed seeking care due to being the sole caregiver for his spouse."
      },
      {
        "id": "opt_02",
        "content": "Bilateral basilar crackles are noted on auscultation."
      },
      {
        "id": "opt_03",
        "content": "Urine output has decreased to 15 mL/hr for the past 2 hours, and the urine is dark amber."
      },
      {
        "id": "opt_04",
        "content": "Morning laboratory results have been reviewed and show a potassium of 6.8 mEq/L and a creatinine of 2.5 mg/dL."
      },
      {
        "id": "opt_05",
        "content": "The client remains on continuous norepinephrine and dobutamine infusions for hemodynamic support."
      }
    ],
    "correctAnswer": [
      "opt_04"
    ]
  },
  "rationale": {
    "correct": "The most critical finding that requires an immediate safety stop is the laboratory result showing severe hyperkalemia (Potassium 6.8 mEq/L) in the setting of acute kidney injury (Creatinine 2.5 mg/dL). Administering the scheduled spironolactone, a potassium-sparing diuretic, is absolutely contraindicated. This action would further increase the serum potassium, potentially leading to life-threatening cardiac dysrhythmias, such as ventricular fibrillation or asystole. This combination of data represents an imminent threat to the client's life that must be addressed before any other action is taken. The nurse's primary responsibility is to recognize this contraindication, withhold the medication, and immediately notify the provider to obtain orders for treating the hyperkalemia.",
    "incorrect": "The other findings, while abnormal and indicative of severe illness, are either expected manifestations of cardiogenic shock or do not represent an immediate contraindication to a scheduled medication. The key is to identify the piece of data that makes a planned nursing action (medication administration) actively harmful and potentially lethal. The severe hyperkalemia coupled with the plan to give a potassium-sparing medication is the clear 'DON'T PROCEED' signal.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Client states he had intermittent chest pain for 3 days but delayed seeking care due to being the sole caregiver for his spouse.",
        "isCorrect": false,
        "justification": "This is a critical piece of the client's history and highlights a social determinant of health (caregiver burden) that contributed to the severity of his condition. However, it is historical data. It does not represent an acute physiological change that creates an immediate contraindication for the 0900 (9:00 AM) medications. While important for the overall plan of care and discharge planning, it is not the most urgent safety issue."
      },
      {
        "label": "B",
        "content": "Bilateral basilar crackles are noted on auscultation.",
        "isCorrect": false,
        "justification": "Bibasilar crackles are an expected clinical sign of pulmonary edema secondary to left ventricular failure in cardiogenic shock. This finding confirms the diagnosis and severity but does not, in itself, contraindicate the administration of the scheduled medications. In fact, the scheduled furosemide is intended to treat this specific finding. It is a serious sign but part of the known clinical picture."
      },
      {
        "label": "C",
        "content": "Urine output has decreased to 15 mL/hr for the past 2 hours, and the urine is dark amber.",
        "isCorrect": false,
        "justification": "Oliguria (urine output < 0.5 mL/kg/hr) is a hallmark of cardiogenic shock and indicates acute kidney injury (AKI) due to poor renal perfusion. This finding is directly related to the high creatinine and potassium. However, the specific lab value (K+ of 6.8) is the direct, quantifiable contraindication to the spironolactone, making it the most critical piece of data to act upon. The oliguria is the symptom; the hyperkalemia is the immediately life-threatening chemical imbalance."
      },
      {
        "label": "D",
        "content": "Morning laboratory results have been reviewed and show a potassium of 6.8 mEq/L and a creatinine of 2.5 mg/dL.",
        "isCorrect": true,
        "justification": "This is the correct answer. A potassium level of 6.8 mEq/L constitutes severe, life-threatening hyperkalemia, which can cause fatal cardiac arrhythmias. The elevated creatinine of 2.5 mg/dL confirms AKI, meaning the client cannot excrete potassium effectively. Administering spironolactone, a potassium-sparing diuretic, would be a lethal medication error. This finding requires the nurse to STOP, withhold the medication, and immediately notify the provider for urgent intervention (e.g., insulin/dextrose, calcium gluconate, dialysis)."
      },
      {
        "label": "E",
        "content": "The client remains on continuous norepinephrine and dobutamine infusions for hemodynamic support.",
        "isCorrect": false,
        "justification": "The use of vasopressors (norepinephrine) and inotropes (dobutamine) is standard, expected management for cardiogenic shock to support blood pressure and cardiac output. This information confirms the severity of the client's condition but does not represent a new, critical change or a contraindication to other scheduled medications. It is part of the ongoing, appropriate treatment plan."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Analyze Cues",
    "nclexCategory": "Reduction of Risk Potential",
    "nclexSubcategory": "Potential for Complications of Diagnostic Tests/Treatments/Procedures",
    "difficulty": "High",
    "topicTags": [
      "Cardiogenic Shock",
      "Medication Safety",
      "Hyperkalemia",
      "Acute Kidney Injury",
      "Pharmacology",
      "Critical Care"
    ]
  },
  "clinicalPearls": [
    "In patients with acute kidney injury and hyperkalemia, always double-check the medication list for potassium-sparing diuretics (e.g., spironolactone, triamterene) and hold them.",
    "Severe hyperkalemia can cause life-threatening cardiac arrhythmias. Prompt recognition and treatment are crucial.",
    "When caring for patients in cardiogenic shock, be vigilant for signs of acute kidney injury, such as decreased urine output and elevated creatinine and potassium levels.",
    "Always correlate clinical findings with laboratory results to make informed decisions about medication administration.",
    "Consider social determinants of health, such as caregiver burden, when assessing patients with chronic conditions. These factors can significantly impact their health outcomes."
  ],
  "sentinelStatus": "healed_v2026"
}